1. Home
  2. BOOM vs VTVT Comparison

BOOM vs VTVT Comparison

Compare BOOM & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DMC Global Inc.

BOOM

DMC Global Inc.

HOLD

Current Price

$6.16

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$35.30

Market Cap

148.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOOM
VTVT
Founded
1965
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.8M
148.7M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
BOOM
VTVT
Price
$6.16
$35.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$8.50
$53.00
AVG Volume (30 Days)
451.8K
41.5K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
89.02
N/A
EPS
N/A
N/A
Revenue
$609,840,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.69
$14.00
52 Week High
$9.20
$44.00

Technical Indicators

Market Signals
Indicator
BOOM
VTVT
Relative Strength Index (RSI) 41.02 52.73
Support Level $6.08 $34.29
Resistance Level $6.35 $42.51
Average True Range (ATR) 0.40 2.37
MACD -0.09 0.24
Stochastic Oscillator 34.59 53.00

Price Performance

Historical Comparison
BOOM
VTVT

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Share on Social Networks: